Changes in Serum and Urine N-Telopeptide Levels of Postmenopausal Osteoporotic Patients Within 6-months of Risedronate Treatment - Original Investigation
Aim: N-Telopeptides (NTX), which are known as bone turnover markers are being increasingly used in early diagnosis of osteoporosis, determining the fracture risk and following up of the treatment outcome. Material and Method: In this study serum and urine NTX levels of postmenapousal patients [ages...
Main Authors: | Murat Zinnuroğlu, Aylin Sepici Dinçel, Vesile Sepici, Gülçin Kaymak Karataş |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Yayinevi
2006-09-01
|
Series: | Türk Osteoporoz Dergisi |
Subjects: | |
Online Access: | http://www.turkosteoporozdergisi.org/article_4154/Changes-In-Serum-And-Urine-N-telopeptide-Levels-Of-Postmenopausal-Osteoporoticpatients-Within-6-months-Of-Risedronate-Treatment-Original-Investigation |
Similar Items
-
Measurement of Urinary N-Telopeptides and Serum C-Telopeptides from Type I Collagen Using a Lateral Flow-Based Immunoassay
by: Kyoung Min Lee, et al.
Published: (2012-12-01) -
Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis
by: Paula Rackoff
Published: (2009-05-01) -
Investigating Correlation between Type I collagen N-Telopeptides X, Morphologic Parameters of Vertebra and DEXA values of the Patients with Postmenopausal Osteoporosis
by: Savaş Gürsoy, et al.
Published: (2002-03-01) -
Maternal type 1collagen N-terminal telopeptide levels in severe hyperemesis gravidarum
by: E. Sahin, et al.
Published: (2018-12-01) -
Impact of Risedronate on Bone Mineral Density and Quality of Life in Postmenopausal Women with Osteoporosis: The Results of 1-Year Follow up
by: Ercan Madenci, et al.
Published: (2003-06-01)